Skip to main content
OpenTrials

Clinical trial condition

Hematologic Neoplasms

Explore clinical trials studying Hematologic Neoplasms. Study availability and eligibility vary by location and protocol.

85 public trials 16 recruiting studies
Refine in advanced search Browse all conditions

Hematologic Neoplasms trial results

Completed

A Phase 1, Dose Finding Study of CC-90002 in Subjects With Advanced Solid and Hematologic Cancers

NCT02367196

Conditions
Hematologic Diseases, Hematologic Neoplasms, Hemic and Lymphatic Diseases, +2 more
Locations
  • Scottsdale Healthcare Research Institute Scottsdale, Arizona, United States
  • University of Arizona Cancer Center Tucson, Arizona, United States
  • University of California San Francisco San Francisco, California, United States
  • Yale University School of Medicine New Haven, Connecticut, United States
View all 13 locations
View Trial Details
Completed

Phase I-II Study to Determine the Maximum Tolerated Dose (MTD) of AUY922 in Advanced Solid Malignancies, and Efficacy in HER2+ or ER+ Locally Advanced or Metastatic Breast Cancer Patients

NCT00526045

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +7 more
Locations
  • UCLA/ University of California Los Angeles UCLA Los Angeles, California, United States
  • Georgia Health Sciences University Med College of GA Augusta, Georgia, United States
  • Dana Farber Cancer Institute StudyCoordinator:CAUY922A2101 Boston, Massachusetts, United States
  • Washington University School Of Medicine-Siteman Cancer Ctr Dept. of Siteman Cancer Ctr. St Louis, Missouri, United States
View Trial Details
Completed

National Marrow Donor Program Long-Term Donor Follow-Up

NCT01362179

Conditions
Hematologic Diseases, Hematologic Neoplasms, Hemic and Lymphatic Diseases, +2 more
Locations
  • City of Hope Duarte, California, United States
  • National Marrow Donor Program Northern California & Northwest District Oakland, California, United States
  • National Marrow Donor Program Southern California & Southwest District Santa Ana, California, United States
  • Colorado Marrow Donor Program Denver, Colorado, United States
View all 29 locations
View Trial Details
Completed

Therapeutic Virtual Reality : Impact on the Management of Pain and Anxiety Related to Hematology Care (REVEH)

NCT03483194

Conditions
Hematologic Diseases, Hematologic Neoplasms, Hemic and Lymphatic Diseases, +2 more
Locations
  • SOL Clinique Sainte-Anne Strasbourg, Alsace, France
  • Institut Bergonié Bordeaux, Gironde, France
  • CHU Angers Angers, Pays de Loire, France
  • Centre Jean Bernard - Clinique Victor Hugo Le Mans, France
View Trial Details
Completed

Platelet Transfusion Requirements in Hematopoietic Transplantation Pilot Study

NCT02650791

Conditions
Hematologic Diseases, Hematologic Neoplasms, Hemic and Lymphatic Diseases, +2 more
Locations
  • Tom Baker Cancer Centre Calgary, Alberta, Canada
  • Hamilton Health Sciences - Juravinski Hospital and Cancer Centre Hamilton, Ontario, Canada
  • London Health Sciences Centre London, Ontario, Canada
  • The Ottawa Hospital Ottawa, Ontario, Canada
View Trial Details
Completed

Study to Allow Access to Single Agent Panobinostat for Patients Who Are on s.a. Panobinostat Treatment in a Novartis-sponsored Study and Continue to Benefit From the Treatment as Judged by the Investigator

NCT01802879

Conditions
Hematologic Diseases, Hematologic Neoplasms, Hemic and Lymphatic Diseases, +2 more
Locations
  • City of Hope National Medical Center Dept.ofCityofHopeMedicalCtr(1) Duarte, California, United States
  • Georgia Regents University SC-2 Augusta, Georgia, United States
  • Dana Farber Cancer Institute Reg. Ped Boston, Massachusetts, United States
  • University of Utah / Huntsman Cancer Institute SC-2 Salt Lake City, Utah, United States
View Trial Details
Completed

Phase I Trial of BAY1251152 for Advanced Blood Cancers

NCT02745743

Conditions
Hematologic Diseases, Hematologic Neoplasms, Hemic and Lymphatic Diseases, +2 more
Locations
  • New York, United States
  • The Bronx, New York, United States
  • Nashville, Tennessee, United States
  • Dresden, Saxony, Germany
View Trial Details

Related conditions